Advertisement

Pharmaceuticals

Drug companies sue to block California drug price law

Drug companies sue to block California drug price law

Pharmaceutical companies have sued to block a new California law that would require them to give advance notice before big price increases. A pharma trade group said in its lawsuit that California's law illegally tries to dictate national health policy.

U.S. approves monthly injection for opioid addiction

U.S. approves monthly injection for opioid addiction

The monthly injection has the potential to reduce dangerous relapses that occur when patients stop taking the currently available daily medication. But that benefit has not yet been shown in studies and the new drug comes with a hefty price: $1,580 per monthly dose.

Policy reforms needed to lower drug prices

Policy reforms needed to lower drug prices

Access to affordable medicine is an unmet public health imperative, according to a new report that recommended government drug price negotiation, competition reform and financial transparency to alleviate the issue.

Azar proposes competition to combat high drug prices

Azar proposes competition to combat high drug prices

In his initial confirmation testimony, former pharma executive and HHS secretary nominee Alex Azar said he would stop drug manufacturers from gaming the system and blocking generic competitors from the market.

FDA to pave clearer path for generic drugs

FDA to pave clearer path for generic drugs

The FDA's new guidance aims to make it easier for generic firms to plan how they can copy complex drugs like epinephrine auto-injectors, which should ultimately lower pharmaceutical prices.

Liquid gold: Pain doctors soak up profits by screening urine for drugs

Liquid gold: Pain doctors soak up profits by screening urine for drugs

Kaiser Health News, with assistance from researchers at the Mayo Clinic, analyzed available billing data from Medicare and private insurance billing nationwide, and found that spending on urine screens and related genetic tests quadrupled from 2011 to 2014 to an estimated $8.5 billion a year.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print